A Comparison of Injection Pain of Propofol During Endoscopy : LCT Propofol vs MCT/LCT Propofol

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02567916

Enrollment

129

Registered

2015-10-05

Start date

2015-04-30

Completion date

2017-02-28

Last updated

2020-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication of Injection, Pain

Brief summary

The purpose of this study is to compare the incidence and intensity of possible pain on injection as well as patient satisfaction caused by long chain triglyceride propofol versus medium/long chain combinated triglyceride propofol on endoscopy.

Interventions

DRUGFresofol

DRUGPropofol

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

15 Years to No maximum

Healthy volunteers

Inclusion criteria

* age \>15 yrs * ASA (American Society of Anesthesiologists risk class III-IV)I-II * patients undergoing to gastroscopy

Exclusion criteria

* significant systemic disease (American Society of Anesthesiologists risk class III-IV) * history of allergic reactions to any of the study drugs * chronic use of opioid analgesics * psychiatric disorder * arrythmia * pregnancy * age \<18 yrs

Design outcomes

Primary

Measure	Time frame
Incidence and Intensity of Pain on Injection That is Caused by Propofol (LCT propofol) Versus the Fresofol (MCT/LCT propofol).	2 hours

Secondary

Measure	Time frame
Patient Satisfaction With Sedation Including the Recall of Pain.	2 hours and 5-7days after the end of the procedure

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026